Common blood thinner can be repurposed as an inexpensive antidote for cobra venom

FHS
July 18, 2024
12:34 pm

Scientists at the University of Sydney and Liverpool School of Tropical Medicine have made a remarkable discovery: a commonly used blood thinner, heparin, can be repurposed as an inexpensive antidote for cobra venom.

Pharmaceutical Technology | Drug Development News & Views Updated DailyHome – Pharmaceutical Technology

Latest Issue Pharma Technology Focus Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read

September 27, 2024

Experts call for clear rules governing human embryo research

Clear rules governing human embryo research must be established to enable regulators, researchers and funders to assess whether stem cell-generated models should be considered as

June 8, 2024

Medacta is pleased to announce the first European Peri-Acetabular Osteotomy procedures using the MyPAO Platform, a unique solution for acetabular realignment – Biotech Investments

Medacta Group SA / Key word(s): Market Launch Medacta is pleased to announce the first European Peri-Acetabular Osteotomy procedures using the MyPAO Platform, a unique

July 5, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.